Education
About Us
Working with TipRanks
Follow Us
Bio-Works Technologies AB (SE:BIOWKS)
:BIOWKS
BIOWKS Stock Chart & Stats
kr2.25
-kr0.03(-1.90%)
At close: 4:00 PM EST
kr2.25
-kr0.03(-1.90%)
Day’s Range― - ―
52-Week Rangekr0.72 - kr3.56
Previous CloseN/A
Volume20.36K
Average Volume (3M)70.02K
Market Cap
kr221.01M
Enterprise Valuekr99.24M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.50
Next Earnings
Feb 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding98,225,120
10 Day Avg. Volume46,662
30 Day Avg. Volume70,017
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BIOWKS FAQ
What was Bio-Works Technologies AB’s price range in the past 12 months?
Bio-Works Technologies AB lowest stock price was kr0.72 and its highest was kr3.56 in the past 12 months.
What is Bio-Works Technologies AB’s market cap?
Bio-Works Technologies AB’s market cap is kr221.01M.
When is Bio-Works Technologies AB’s upcoming earnings report date?
Bio-Works Technologies AB’s upcoming earnings report date is Feb 20, 2026 which is in 56 days.
How were Bio-Works Technologies AB’s earnings last quarter?
Bio-Works Technologies AB released its earnings results on Nov 07, 2025. The company reported -kr0.017 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.017.
Is Bio-Works Technologies AB overvalued?
According to Wall Street analysts Bio-Works Technologies AB’s price is currently Overvalued.
Does Bio-Works Technologies AB pay dividends?
Bio-Works Technologies AB does not currently pay dividends.
What is Bio-Works Technologies AB’s EPS estimate?
Bio-Works Technologies AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bio-Works Technologies AB have?
Bio-Works Technologies AB has 98,225,120 shares outstanding.
What happened to Bio-Works Technologies AB’s price movement after its last earnings report?
Bio-Works Technologies AB reported an EPS of -kr0.017 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 13.636%.
Which hedge fund is a major shareholder of Bio-Works Technologies AB?
Currently, no hedge funds are holding shares in SE:BIOWKS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Bio-Works Technologies AB
Bio-Works Technologies AB is a Sweden-based life science company which is engaged in designing, developing, manufacturing and supplying products for purification and separation of proteins and other molecules. The product line of the company includes activated resin, immobilized metal-ion affinity chromatography resin, ion exchange chromatography resin, size exclusion chromatography resin and others. The company has also developed affinity chromatography technique, BabyBio Columns, OptiBio glass columns for separating proteins, and protein purification. Bio-Works serves various end users such as academic research laboratories, biopharmaceutical companies, the food and beverage industry and others.
Technical Analysis
Isofol Medical AB
―
Xintela AB
―
Elicera Therapeutics AB
―
IRLAB Therapeutics AB Class A
―
Active Biotech AB
―